Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Angus

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Molecular Cancer Therapeutics|August 28, 2020
<i>Nf1</i>-Mutant Tumors Undergo Transcriptome and Kinome Remodeling after Inhibition of either mTOR or MEKDaniela Pucciarelli, Steven P Angus, Benjamin Huang, et al.
Frontiers in Oncology|June 10, 2024
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of <i>PTEN</i>-null, <i>BRAFV600E</i> melanoma to BRAF/MEK inhibitionEvan DuBose, Samantha M Bevill, Dana K Mitchell, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
A novel induced pluripotent stem cell model of Schwann cell differentiation reveals <i>NF2</i> - related gene regulatory networks of the extracellular matrixOlivia Lazaro, Sihong Li, William Carter, et al.
Cancer Research|November 29, 2017
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital ImagingHailey E Brighton, Steven P Angus, Tao Bo, et al.
Journal of the American Heart Association|October 21, 2017
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor InhibitionTimothy J Stuhlmiller, Jon S Zawistowski, Xin Chen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 1, 2020
A molecular basis for neurofibroma-associated skeletal manifestations in NF1Yun Ma, Andrea M Gross, Eva Dombi, et al.
Targeted Oncology|August 21, 2019
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing LymphomaSteven I Park, Carolina P Lin, Natalie Ren, et al.
Research Square|June 30, 2025
An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networksOlivia Lazaro, Sihong Li, William Carter, et al.
Cancer Discovery|June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology GroupElliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Molecular Cancer Research : MCR|April 20, 2019
GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast CancerSamantha M Bevill, Jose F Olivares-Quintero, Noah Sciaky, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|August 28, 2020
<i>Nf1</i>-Mutant Tumors Undergo Transcriptome and Kinome Remodeling after Inhibition of either mTOR or MEKDaniela Pucciarelli, Steven P Angus, Benjamin Huang, et al.
Frontiers in Oncology|June 10, 2024
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of <i>PTEN</i>-null, <i>BRAFV600E</i> melanoma to BRAF/MEK inhibitionEvan DuBose, Samantha M Bevill, Dana K Mitchell, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
A novel induced pluripotent stem cell model of Schwann cell differentiation reveals <i>NF2</i> - related gene regulatory networks of the extracellular matrixOlivia Lazaro, Sihong Li, William Carter, et al.
Cancer Research|November 29, 2017
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital ImagingHailey E Brighton, Steven P Angus, Tao Bo, et al.
Journal of the American Heart Association|October 21, 2017
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor InhibitionTimothy J Stuhlmiller, Jon S Zawistowski, Xin Chen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 1, 2020
A molecular basis for neurofibroma-associated skeletal manifestations in NF1Yun Ma, Andrea M Gross, Eva Dombi, et al.
Targeted Oncology|August 21, 2019
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing LymphomaSteven I Park, Carolina P Lin, Natalie Ren, et al.
Research Square|June 30, 2025
An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networksOlivia Lazaro, Sihong Li, William Carter, et al.
Cancer Discovery|June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology GroupElliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Molecular Cancer Research : MCR|April 20, 2019
GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast CancerSamantha M Bevill, Jose F Olivares-Quintero, Noah Sciaky, et al.
Pageof 6